A heart attack and stroke are both medical emergencies caused by sudden disruption of blood flow, but they affect different ...

Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.

Extra scrutiny is warranted to identify the underlying causes of chest pain in patients with nonobstructive coronary disease ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

The company highlighted active regulatory engagement with both the FDA and Japan’s PMDA, setting the stage for possible approval submissions in multiple geographies. Clinical trial data across both ...

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...

The Librexia clinical trial program includes two other Phase 3 trials, Librexia AF for patients with atrial fibrillation (AF) and Librexia STROKE for secondary stroke prevention (SSP). The IDMC ...

AI-enabled wearables are transforming preventive health by detecting abnormal heart rhythms, seizure-risk patterns and stress ...

The main goal in STEMI is to restore blood flow to reduce myocardial injury, Mehran explained. The novel glycoprotein IIb/IIIa inhibitor locks the receptor in its inactive position, which can reduce ...

Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...

All experimental procedures were approved by the University of Toronto Animal Care and Use Committee and follow the rules set out by the Guide for the Care and Use of Laboratory Animals published by ...